Affordable Access

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.

Authors
Type
Published Article
Journal
JAMA
Publication Date
Volume
267
Issue
14
Pages
1947–1951
Identifiers
PMID: 1548827
Source
Medline
License
Unknown

Abstract

Aerosolized rhDNase appears safe in normal subjects and in adults with cystic fibrosis and may improve lung function with short-term therapy.

Statistics

Seen <100 times